Join the Pravachol group to help and get support from people like you.
Pravachol News
Statin Use Increased From 1999-2000 to 2013-2014, Then Plateaued
MONDAY, Dec. 4, 2023 – Overall statin use for primary prevention increased since 1999 to 2000 but has plateaued since 2013 to 2014, according to a research letter published online Dec. 5 in the...
Gaps Persist in Actual Versus Optimal Atherosclerotic Cardiovascular Disease Care
TUESDAY, Dec. 5, 2023 – Roughly half of patients with atherosclerotic cardiovascular disease (ASCVD) adopt optimal prevention strategies across racial and ethnic subgroups, according to a study...
Lipid-Lowering Drugs Save Lives, but Use Decreasing
FRIDAY, Dec. 1, 2023 – Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16...
High-Intensity Statins Underused With Atherosclerotic Cardiovascular Disease
TUESDAY, Sept. 19, 2023 – Among patients with atherosclerotic cardiovascular disease (ASCVD), high-intensity statins are underutilized in routine care, according to a study published online Aug. 2...
FDA Medwatch Alert: FDA Requests Removal of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy; Still Advises Most Pregnant Patients Should Stop Taking Statins
What safety information is FDA announcing? The U.S. Food and Drug Administration (FDA) is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant...
FDA Medwatch Alert: Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling
ISSUE: International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The...
FDA Medwatch Alert: Red Yeast Rice by Doctor’s Best: Recall - Undeclared Lovastatin
ISSUE: Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Doctor’s Best Red Yeast Rice has ...
FDA Medwatch Alert: Statins and HIV or Hepatitis C Drugs: Drug Safety Communication - Interaction Increases Risk of Muscle Injury
ISSUE: FDA notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. Protease inhibitors and statins ...
FDA Medwatch Alert: Statin Drugs - Drug Safety Communication: Class Labeling Change
ISSUE: FDA has approved important safety label changes for the class of cholesterol-lowering drugs known as statins. The changes include removal of routine monitoring of liver enzymes from drug...
FDA Medwatch Alert: Statin drugs and amyotrophic lateral sclerosis (ALS)
[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as...
Further information
Related condition support groups
High Cholesterol - Familial Heterozygous, High Cholesterol